Skip to Content
Merck
CN
HomeProductsMolecular Biology & Functional GenomicsGene Editing & Functional Genomics

Gene Editing & Functional Genomics

Sigma-Aldrich® Advanced Genomics offers a complete suite of genome engineering and modulation products and services. Our comprehensive portfolio delivers support for every step of your research, from discovery through translational research to therapeutic impact.  

Target a single gene or screen a whole genome with fully customizable products. With tools to edit using CRISPR or ZFNs, modulate expression with CRISPRa/i or RNAi, or perform whole genome screens, you’re limited only by your scientific curiosity. And with over 350 years of technical leadership, Sigma-Aldrich® Advanced Genomics offers an unsurpassed breadth of expertise and intellectual property to help you succeed.

The image features a digitally rendered DNA double helix with a segment highlighted in pink, set against a soft, cloudy background. The DNA strands have a crystalline appearance, and the pink highlight draws attention to a specific gene or mutation. The ethereal atmosphere is created by the shades of white and grey.
CRISPR & Gene Editing

With decades of gene editing experience and an unsurpassed portfolio of CRISPR and ZFN technology patents, Sigma-Aldrich® Advanced Genomics delivers the highest quality reagents for your entire workflow, from early-stage discovery to translational research. Whether you are looking to knockout, knock-in, knockdown, or overexpress your targets, our comprehensive suite of CRISPR gene-editing tools and services will take your research Beyond the Bench.

The image is an artistic illustration that portrays a microscopic view of various cells and microorganisms. It features several purple spiral bacteria at the center, surrounded by different types of cells and particles in red and white. The background is a blend of light blue and pink hues, creating an ethereal effect, with a larger yellow cell structure partially visible in the center-back.
RNAi Single Clones

Sigma-Aldrich® Advanced Genomics RNAi Single Clones deliver powerful, long term, and stable gene silencing. As an exclusive provider of the TRC1.5 and TRC2 collections from The RNAi Consortium (TRC), our comprehensive offering consists of nearly 200,000 pre-cloned shRNA constructs targeting more than 22,500 human and 20,000 mouse genes. 

The image presents a close-up view of virus particles, with a dominant golden particle in the center, characterized by its spherical shape and numerous spike proteins. The background features additional particles in golden-yellow and blue hues, all set against a blurred backdrop that accentuates the central figure and adds depth to the composition. The image captures the intricate details and diversity of virus particles, highlighting their unique structures.
RNAi Libraries

Sigma-Aldrich® Advanced Genomics is the exclusive provider of the TRC1.5 and TRC2 collections from The RNAi Consortium (TRC). These lentivirus-based shRNA libraries deliver unparalleled coverage and are available in multiple formats that include whole-genome, individual RNAi clones/vectors, and gene family sets. Available in standard glycerol format or higher quality DNA and lentiviral formats.

The image showcases a close-up view of a multi-well plate being filled with a red liquid by an automated pipetting system. The pipettes are aligned and dispensing the liquid into the wells in unison, with a blurred background emphasizing the precision of the process. This scene is typical in laboratory settings where multiple samples are processed simultaneously for experiments or testing.
Genetic Screening

Sigma-Aldrich® Advanced Genomics offers complete solutions for your genetic screens at any scale. Whether you're targeting specific genes or performing a genome-wide screen, we offer extensive pooled and arrayed formats to meet your needs. From gene expression knockdown with CRISPRi and RNAi to overexpression with CRISPRa and ORF, we have everything you need for your target discovery research.

Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?